News Boosted by new drugs, Boehringer shrugs off patent expiry BI boosted by new diabetes and respiratory drugs.
News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News Sanofi cholesterol drug can stay on US market - for now Sales of Praluent can continue during patent case appeal.
News Enbrel unlikely to face Novartis rival until 2018 Amgen arguing that US patent will last until 2029.
News Novartis less exposed to US pricing pressure, says Jimenez Europe and Asia account for a large share of company's income.
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
